Pregled bibliografske jedinice broj: 551869
CSF total tau and tau protein phosphorylated at threonine 181 in the differential diagnosis of Alzheimer's disease and vascular cognitive impairment
CSF total tau and tau protein phosphorylated at threonine 181 in the differential diagnosis of Alzheimer's disease and vascular cognitive impairment // European Journal of Neurology 18 (Suppl. 2) - Abstracts of the 15th congress of the European Federation of Neurological Societies
Budimpešta, Mađarska, 2011. str. 414-414 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 551869 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
CSF total tau and tau protein phosphorylated at threonine 181 in the differential diagnosis of Alzheimer's disease and vascular cognitive impairment
Autori
Boban, Marina ; Šarac, Helena ; Mladinov, Mihovil ; Süßmair, Christine ; Ackl, Nibal ; Bader, Benedikt ; Danek, Adrian ; Mimica, Ninoslav ; Hof, Patrick R ; Šimić, Goran
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
European Journal of Neurology 18 (Suppl. 2) - Abstracts of the 15th congress of the European Federation of Neurological Societies
/ - , 2011, 414-414
Skup
15th congress of the European Federation of Neurological Societies
Mjesto i datum
Budimpešta, Mađarska, 09.09.2011. - 13.09.2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Cerebrospinal fluid; dementia; Alzheimer's disease; vascular cognitive impairment
Sažetak
Alzheimer's disease (AD) and vascular cognitive impairment (VCI) are the two most common causes of dementia in older age groups. Due to inadequacy of current clinical diagnostic criteria in differential diagnosis of dementia, the identification of new biomarkers that would help establishing the diagnosis and primary cause of the dementia is therefore of great relevance. The aim of this study was to investigate the diagnostic accuracy of two potential CSF biomarkers, total tau protein (t-tau) and tau protein phosphorylated at threonine 181 (p-tau181) in the differential diagnosis of patients with AD and VCI. The concentrations of CSF biomarkers were measured in 29 AD patients, 12 VCI patients and 25 control subjects. The CSF concentrations of both markers were significantly higher in AD group compared to VCI (p>0.001) group and control subjects (p<0.001) ; however none fulfilled the criteria for the "ideal" marker (sensitivity and specificity higher than 85%). Finally, using logistic regression analysis with t-tau and p-tau181 as independent variables led to improvement in diagnostic accuracy with correct classification in more than 85% of cases.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081870-1942 - Fosforilacija tau proteina u razvitku i Alzheimerovoj bolesti (Šimić, Goran, MZOS ) ( CroRIS)
108-1080003-0019 - Klinička farmakologija poremećaja pokreta (Relja, Maja, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče,
Klinički bolnički centar Zagreb
Profili:
Ninoslav Mimica
(autor)
Marina Boban
(autor)
Helena Šarac
(autor)
Goran Šimić
(autor)
Mihovil Mladinov
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE